全文获取类型
收费全文 | 297篇 |
免费 | 11篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 1篇 |
妇产科学 | 3篇 |
基础医学 | 3篇 |
口腔科学 | 1篇 |
临床医学 | 14篇 |
内科学 | 48篇 |
皮肤病学 | 1篇 |
神经病学 | 7篇 |
特种医学 | 2篇 |
外科学 | 16篇 |
综合类 | 1篇 |
预防医学 | 128篇 |
药学 | 4篇 |
中国医学 | 2篇 |
肿瘤学 | 78篇 |
出版年
2024年 | 2篇 |
2023年 | 37篇 |
2022年 | 53篇 |
2021年 | 60篇 |
2020年 | 34篇 |
2019年 | 8篇 |
2018年 | 6篇 |
2017年 | 15篇 |
2016年 | 16篇 |
2015年 | 13篇 |
2014年 | 12篇 |
2013年 | 11篇 |
2012年 | 2篇 |
2010年 | 6篇 |
2009年 | 14篇 |
2008年 | 1篇 |
2007年 | 4篇 |
2006年 | 2篇 |
2005年 | 1篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 3篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1993年 | 1篇 |
排序方式: 共有309条查询结果,搜索用时 15 毫秒
71.
72.
73.
《European journal of cancer (Oxford, England : 1990)》2015,51(9):1188-1198
BackgroundInternational comparisons of cancer registry based survival are often used as a marker of the performance of health care services on cancer. These are debated for comparability, validity and lack of detail with respect to prognostic factors. With a view to cross border collaborative cancer research and care in the European Union (EU), we used the established routine registration systems for cancer in the neighbouring regions Zealand, Denmark, and Schleswig-Holstein, Germany, to study if available routine registration suffices for the study of diagnosis, treatment and follow-up for colorectal cancer patients. The aim was to assess to which extent differences in survival between the regions could be explained.MethodsColorectal cancer patients recorded 2004–2010 in Schleswig-Holstein (colon: 10,631; rectum 5683) and region Zealand (colon: 3205; rectum 1747) were studied. Excluding cases aged 90+ or only known from death certificates, one- and four-year relative survival by stage for the periods 2004–2006 and 2007–2009 (one-year) were calculated.FindingsA high proportion of patients in Schleswig-Holstein were known only from death certificates (colon 11%; rectum 6.9%) compared to <0.3% in region Zealand. Colon cancer incidence (asr-e) (men 36; women 28) and mortality (men 12; women 8.7) in Schleswig-Holstein were 10 per 100,000 lower than in Zealand; minor differences were seen for rectum cancer. One and four-year overall survival increased in both regions but was superior in Schleswig-Holstein. For patients with reported stage I–III, negligible differences in survival were seen; with further restriction to patients with treatment reported, even so in stage IV patients 2007–2009.InterpretationImproved data quality and comparability than presently used in the large international survival studies is needed. If stage and treatment is taken into account, more valid international comparisons of cancer survival are possible. Reporting and follow-up must be improved and cases only known from death certificates (DCO) minimised. A high proportion DCO (excluded from analyses) may produce higher survival, whereas a low the opposite. Co-morbidity and socio-economic status should be included alongside other prognostic variables in survival studies. Barriers towards proper follow-up and monitoring of outcome e.g. privacy legislation must be considered with a view to future patient mobility. 相似文献
74.
75.
76.
77.
78.
ObjectivesThe aim of this study was to determine whether quercetin can reduce iron overload and inflammation in thalassemic patients.MethodsEighty four patients were recruited to this study and randomly assigned to two groups: 42 patients received a 500 mg/day quercetin tablet and 42 others took a 500 mg/day starch placebo for 12 weeks. Demographic, anthropometric and biochemical evaluation were performed.ResultsANCOVA analysis revealed that compared to the control group, quercetin could reduce high sensitivity C-reactive protein (hs-CRP) (P = 0.046), iron (p = 0.036), ferritin (p = 0.043), and transferrin saturation (TS) (p = 0.008) and increase transferrin (p = 0.045) significantly, but it had no significant effect on total iron binding capacity (TIBC) (p = 0.734) and tumor necrosis factor α (TNF-α) (p = 0.310).ConclusionsQuercetin could ameliorate the iron status in thalassemia major, but its effect on inflammation is indistinctive. 相似文献
79.
Huiping Li Xuena Wang Mingxu Ye Shunming Zhang Qing Zhang Ge Meng Li Liu Hongmei Wu Yeqing Gu Yawen Wang Tingjing Zhang Shaomei Sun Xing Wang Ming Zhou Qiyu Jia Kun Song Yaogang Wang Kaijun Niu 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(6):1691-1701
Background and aimsResults of in vitro and in vivo studies showed that green leafy vegetables (GLV) could attenuate liver steatosis. However, little is known regarding the association between GLV intake and nonalcoholic fatty liver disease (NAFLD) in human. We examined the association of GLV intake with NAFLD in a large-scale adult population.Methods and resultsThis cross-sectional study investigated 26,891 adults in China who participated in health examinations from 2013 to 2017. Newly diagnosed NAFLD was detected by liver ultrasonography. Dietary intake was assessed by using a validated and standardized food frequency questionnaire. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) across categories of GLV intake. After adjustment for sociodemographic characteristics, lifestyle factors, and other dietary intakes, the OR (95% CI) for comparing the highest vs. lowest GLV intake categories (≥7 times/week vs. almost never) was 0.72 (0.59, 0.90) (P < 0.0001). In addition, a linear inverse association was demonstrated between GLV intake and NAFLD in women (P for trend = 0.04), but ORs for any intake category did not reach significance. Stratified analyses suggested a potential effect modification by obesity status; the ORs (95% CIs) for comparing the highest vs. lowest GLV intake categories was 0.72 (0.54, 0.97) in normal/overweight individuals and 1.04 (0.65, 1.65) in obese individuals (P-interaction < 0.0001).ConclusionThis large population-based study shows that high GLV intake is inversely associated with NAFLD, particularly in women and non-obese participants. 相似文献
80.